Switch to:
More From Other Websites
CEL SCI CORP Files SEC form 8-K, Other Events Dec 22 2016
NEW STORY CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 21 2016
CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 20 2016
CEL SCI CORP Financials Dec 20 2016
Cel-Sci reports 4Q loss Dec 14 2016
Cel-Sci reports 4Q loss Dec 14 2016
CEL-SCI Reports Fiscal 2016 Financial Results and Clinical & Corporate Developments Dec 14 2016
CEL SCI CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule... Dec 14 2016
CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan Dec 09 2016
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 02 2016
CEL-SCI Announces Pricing of $4.25 Million Public Offering of Common Stock and Warrants Dec 02 2016
CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants Dec 01 2016
NEW STORY CEL-SCI Submits Response to FDA in Connection with Partial Clinical Hold on Phase 3... Nov 21 2016
CEL-SCI Submits Response to FDA in Connection with Partial Clinical Hold on Phase 3 Clinical Trial Nov 21 2016
NEW STORY CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine Is Successful In Treating... Nov 14 2016
CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine is Successful in Treating Rheumatoid... Nov 14 2016
NEW STORY CEL-SCI Provides Update on Partial Clinical Hold on Phase 3 Clinical Trial Oct 21 2016
CEL-SCI Provides Update on Partial Clinical Hold on Phase 3 Clinical Trial Oct 21 2016
ETF’s with exposure to CEL-SCI Corp. : October 18, 2016 Oct 18 2016
CVR Medical Retains Brisco Capital Investor Relations Sep 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK